Stuart Williamson
8PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 22, 2025
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.Valentina Cutano, Ming Li Chia, Eleanor M Wigmore
|Feb 27, 2024
Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.Emily C Erickson, Inchul You, Grace Perry
|Feb 23, 2024
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.Cath Eberlein, Stuart C Williamson, Lorna Hopcroft
|Sep 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.Mandy Lawson, Natalie Cureton, Susana Ros
|Aug 18, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson
Pageof 2
Frequent Collaborators
7 joint publications
Simon T Barry
6 joint publications
Susana Ros
4 joint publications
Lorna Hopcroft
4 joint publications
Larissa S Carnevalli
4 joint publications
Elza DeBruin
2 joint publications
Jennifer Moss
1 joint publications
Julia Arand
1 joint publications
Laurent Le Cam
1 joint publications
Lauren Averett Byers
1 joint publications
Kévin Contrepois
